Memory-related neural systems in Alzheimer’s disease: An anatomic study

Neurology

Volumn 40, Issue 11, 1990, Pages 1721-1730

  Hyman, B T ^a   Van Hoesen, G W ^b   Damasio, A R ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; AUTOPSY; CLINICAL ARTICLE; CONFERENCE PAPER; HIPPOCAMPUS; HISTOCHEMISTRY; HISTOLOGY; HUMAN; MEMORY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYGDALA; BRAIN; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; MEMORY; MIDDLE AGE; NEUROFIBRILS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TEMPORAL LOBE;

EID: 0025107676     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.40.11.1721     Document Type: Article

References (63)

1. Terry RD, Katzman R. Senile dementia of the Alzheimer type. Ann Neurol 1983;14:497-506.
2. Scoville WB, Milner B. Loss of recent memory after bilateral hippocampal lesions. J Neurol Neurosurg Psychiatry 1957;20:11-21.
3. Zola-Morgan S, Squire LR, Amaral DG. Human amnesia and the medial temporal region; memory impairment following a bilateral lesion limited to the CA1 field of the hippocampus. J Neurosci 1986;6:2950-2967.
4. Damasio AR, Eslinger PJ, Damasio H, Van Hoesen GW, Cornell S. Multimodal amnesic syndrome following bilateral temporal and basal forebrain damage. Arch Neurol 1985;42:252-259.
5. Squire LR, Zola-Morgan S. The neurology of memory: the case for correspondence between the findings for human and nonhuman primate. In: Deutsch JA, ed. The physiological basis of memory, chap 6. New York: Academic Press, 1983.
6. Mishkin M. A memory system in the monkey. Philos Trans R Soc Lond (Biol) 1982;298:83-95.
7. Hyman BT, Damasio AR, Van Hoesen GW, Barnes CL. Alzheimer’s disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170.
8. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR. Perforant pathway changes and the memory impairment of Alzheimer’s disease. Ann Neurol 1986;20:472-481.
9. Van Hoesen GW. The differential distribution, diversity and sprouting of cortical projections to the amygdala in the rhesus monkey. In: Ben-Ari Y, ed. The amygdaloid complex. Amsterdam: Elsevier, 1981:77-90.
10. Van Hoesen GW. The primate parahippocampal gyrus: new insights regarding its cortical connections. Trends Neurosci 1982;5:345-350.
11. Pandya DN, Yeterian EJ. Architecture and connections of cortical association areas. In: Peters A, Jones EG, eds. Cerebral cortex, vol 4. New York: Plenum Publishing, 1985:3-61.
12. Mirra SS, Brownlee LM, Sumi SM, Hughes JP, Heyman A. CERAD neuropathology protocol: preliminary report on 65 cases clinically diagnosed as Alzheimer’s disease [Abstract]. Neurology 1989;39(Suppl 1):192.
13. Wolozin BL, Pruchnicki A, Dickson DW, Davies P. A neuronal antigen in the brains of Alzheimer’s patients. Science 1986;232:648-650.
14. Hyman BT, Van Hoesen GW, Wolozin BL, Davies P, Kromer LJ, Damasio AR. Alz-50 antibody recognizes Alzheimer-related neuronal changes. Ann Neurol 1988;23:371-379.
15. Davies L, Wolska B, Hilbich C, et al. A4 amyloid protein deposition and the diagnosis of Alzheimer’s disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology 1988;38:1688-1693.
16. Wolozin B, Davies P. Alzheimer-related neuronal protein A68: specificity and distribution. Ann Neurol 1987;22:521-526.
17. Nukina N, Kosik KS, Selkoe DJ. The monoclonal antibody Alz-50 recognizes tau proteins in Alzheimer’s disease brain. Neurosci Lett 1988;87:240-246.
18. Love S, Saitoh T, Quijada S, Cole GM, Terry RD. Alz-50, ubi- quitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies, and Lewy bodies. J Neuropathol Exp Neurol 1988;47:393-405.
19. Hyman BT, Van Hoesen GW, Beyreuther K, Masters CL. A4 amyloid protein immunoreactivity is present in Alzheimer’s disease neurofibrillary tangles. Neurosci Lett 1989;101:352-355.
20. Hyman BT, Van Hoesen GW. Hierarchical vulnerability of the entorhinal cortex and the hippocampal formation to Alzheimer neuropathological changes: a semiquantitative study [Abstract]. Neurology 1990;40(Suppl 1):403.
21. Ball MJ. Topographic distribution of neurofibrillary tangles and granulovacuolar degeneration in hippocampal cortex of aging and demented patients: a quantitative study. Acta Neuropathol (Berl) 1978;42:73-80.
22. Geddes JW, Monaghan DT, Cotman CW, Loh IT, Kim RC, Chui HC. Plasticity of hippocampal circuitry in Alzheimer’s disease. Science 1985;230:1170-1181.
23. Gibson PH. Form and distribution of senile plaques seen in silver impregnated sections in the brains of intellectually normal elderly people and people with Alzheimer-type dementia. Neuropathol Appl Neurobiol 1983;9:379-389.
24. Corsellis JAN. The limbic areas in Alzheimer’s disease and in other conditions associated with dementia. In: Wolstenholme GWE, O’Connor M, ed. Alzheimer’s disease and related conditions. London: J&A Churchill, 1970:37-45.
25. Hirano A, Zimmerman HM. Alzheimer’s neurofibrillary changes. Arch Neurol 1962;7:73-88.
26. Braak N, Braak E. On areas of transition between entorhinal allocortex and temporal isocortex in the human brain: normal morphology and lamina-specific pathology in Alzheimer’s disease. Acta Neuropathol (Berl) 1985;68:325-332.
27. Kromer Vogt LJ, Hyman BT, Van Hoesen GW, Damasio AR. Pathological alterations in the amygdala in Alzheimer’s disease. Neuroscience (in press).
28. Brashear HR, Godec MS, Carlsen J. The distribution of neuritic plaques and acetylcholinesterase staining in the amygdala in Alzheimer’s disease. Neurology 1988;38:1694-1699.
29. Unger JW, McNeill TH, Lapham LL, Hamill RW. Neuropeptides and neuropathology in the amygdala in Alzheimer’s disease: relationship between somatostatin, neuropeptide Y and subregional distribution of neuritic plaques. Brain Res 1988;452:293-302.
30. Herzog AG, Kemper TL. Amygdaloid changes in aging and dementia. Arch Neurol 1980;37:625-629.
31. Witter MP, Van Hoesen GW, Amaral DG. Topographical organization of the entorhinal projection to the dentate gyrus of the monkey. J Neurosci 1989;9:216-228.
32. Price JL, Russchen FT, Amaral DG. The limbic region. II. The amygdaloid complex. In: Bjorklund A, Hokfelt T, Swanson SW, eds. Handbook of chemical neuroanatomy, vol 5. Integrated systems of the CNS, part I. New York: Elsevier Science Publishers, 1987:279-388.
33. Aggleton JP. A description of the amygdalo-hippocampal interconnections in the macaque monkey. Exp Brain Res 1986;64:515-526.
34. Saunders RC, Rosene DL, Van Hoesen GW. Comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey. II. Reciprocal and nonreciprocal connections. J Comp Neurol 1988;271:185-207.
35. Saunders RC, Rosene DL. A comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey. I. Convergence in entorhinal, prorhinal and perirhinal cortices. J Comp Neurol 1988;271:153-184.
36. Swanson LW, Kohler C. Anatomical evidence for direct projections from the entorhinal area to the entire cortical mantle in the rat. J Neurosci 1986;6:3010-3023.
37. Kosel KC, Van Hoesen GW, Rosene DL. Nonhippocampal cortical projections from the entorhinal cortex in the rat and rhesus monkey. Brain Res 1982;244:201-214.
38. Rosene DL, Van Hoesen GW. The hippocampal formation of the primate brain. In: Jones EG, Peters A, eds. The cerebral cortex, vol 6, New York: Plenum Publishing, 1987:345-456.
39. Kang J, Lemaire H-G, Unterbeck A, et al. The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987;325:733-736.
40. Hyman BT, Van Hoesen GW, Damasio AR. Alzheimer’s disease: glutamate depletion in the hippocampal perforant pathway zone. Ann Neurol 1987;22:37-40.
41. Hyman BT, Kromer U, Van Hoesen GW. Reinnervation of the hippocampal perforant pathway zone in Alzheimer’s disease. Ann Neurol 1987;21:259-267.
42. Hyman BT, Kromer LJ, Van Hoesen GW. A direct demonstration of the perforant pathway terminal zone in Alzheimer’s disease using the monoclonal antibody Alz-50. Brain Res 1988;450:392-397.
43. Beal MF, Martin JB. Neuropeptides in neurological disease. Ann Neurol 1986;20:547-565.
44. Kemper TL. Senile dementia: a focal disease in the temporal lobe. In: Nandy K, ed. Senile dementia: a biomedical approach. Amsterdam: Elsevier, 1978:105-113.
45. Brim A, Gustafson L. Distribution of cerebral degeneration in Alzheimer’s disease. Acta Psychiatr Nervenkr 1976;223:15-33.
46. Rogers J, Morrison JH. Quantitative morphology and regional laminar distributions of senile plaques in Alzheimer’s disease. J Neurosci 1985;5:2801-2808.
47. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer’s disease. Proc Natl Acad Sci USA 1985;82:4531-4534.
48. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer’s disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981;10:122-126.
49. Mann D, Yakes P, Mareyniak B. A comparison of changes in the nucleus basalis and locus coeruleus in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1984;47:201-203.
50. Yamamoto T, Hirano A. Nucleus raphe dorsalis in Alzheimer’s disease: neurofibrillary tangles and loss of large neurons. Ann Neurol 1985;17:573-577.
51. Davies P, Maloney AFJ. Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 1976;1:1403.
52. Mesulam M-M, Mufson EJ, Levey AI, Wainer BH. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominate) and hypothalamus in the rhesus monkey. J Comp Neurol 1983;214:170-197.
53. Mesulam M-M, Mufson EJ. Neural inputs into the nucleus basalis of the substantia innominata (CH4) in the rhesus monkey. Brain Res 1984;107:253-274.
54. Damasio A, Graff-Radford N, Eslinger P, Damasio H, Kassell N. Amnesia following basal forebrain lesions. Arch Neurol 1985;42:263-271.
55. Van Hoesen GW, Damasio AR. Neuronal correlates of cognitive impairment in Alzheimer’s disease. In: Plum F, ed. The handbook of physiology, vol 5. Baltimore: American Physiology Society, 1987:871-898.
56. Hyman BT, Maskey KP, Van Hoesen GW, Damasio AR. The auditory system in Alzheimer’s disease (AD): hierarchical pattern of pathology [Abstract], Neurology 1988;38(Suppl 1):133.
57. Lewis DA, Campbell MJ, Terry RD, Morrison JH. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer’s disease: a quantitative study of visual and auditory cortices. J Neurosci 1987;7:1799-1808.
58. Hyman BT, Maskey K, Van Hoesen GW, Kromer LJ, Damasio AR. Pathologic changes in the multimodal association areas of the superior temporal sulcus in Alzheimer’s disease [Abstract]. Neurology 1987;37(Suppl 1):168.
59. Damasio AR. Time-locked multiregional retroactivation: a systems level model for some neural substrates of recall and cognition. Cognition 1989;33:25-62.
60. Damasio AR. The brain binds entities and events by multiregional activation from convergence zones. Neural Computation 1989;1:123-132.
61. Ulrich J, Stahelin HB. The variable topography of Alzheimer type changes in senile dementia and normal old age. Gerontology 1984;30:210-214.
62. Arriagada P, Hyman BT. Topographic distribution of Alzheimer neuronal changes in normal aging brains [Abstract]. J Neu- ropathol Exp Neurol 1990;49:226.
63. Mann DMA, Brown AMT, Prinja D, Jones D, Davies CA. A morphological analysis of senile plaques in the brains of nondemented persons of different ages using silver, immu- nocytochemical, and lectin histochemical staining techniques. Neuropathol Appl Neurobiol (in press).